VERMOX (Janssen Pharmaceuticals, Inc.)


Welcome to the PulseAid listing for the VERMOX drug offered from Janssen Pharmaceuticals, Inc.. This Antihelminthic [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Janssen Pharmaceuticals, Inc.
NON-PROPRIETARY NAME: mebendazole
SUBSTANCE NAME: MEBENDAZOLE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Antihelminthic [EPC]
ROUTE: ORAL
DOSAGE FORM: TABLET, CHEWABLE
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2016-10-20
END MARKETING DATE: 0000-00-00


VERMOX HUMAN PRESCRIPTION DRUG Details:

Item DescriptionVERMOX from Janssen Pharmaceuticals, Inc.
LABELER NAME: Janssen Pharmaceuticals, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 500(mg/1)
START MARKETING DATE: 2016-10-20
END MARKETING DATE: 0000-00-00
PRODUCT ID: 50458-675_086f72d0-a9b6-46ea-ac0d-53a4999fa3a2
PRODUCT NDC: 50458-675
APPLICATION NUMBER: NDA208398

Other MEBENDAZOLE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Amedra Pharmaceuticals LLCEMVERM
Bryant Ranch PrepackMebendazole
Impax Specialty PharmaEMVERM
Janssen Pharmaceuticals, Inc.VERMOX
Johnson & Johnson Consumer Inc, McNeil Consumer Healthcare DivisionVERMOX
Physicians Total Care, Inc.MEBENDAZOLE